|
| ||
|
|
||
Bioactive Materials (bioactive + material)
Selected AbstractsGeneration of Bioactive Materials with Rapid Self-Assembling Resorcinarene-PeptidesADVANCED MATERIALS, Issue 28 2009Mirren Charnley Adhesive resorcinarene molecules rapidly self-assemble on a wide range of material surfaces. We have created resorcinarenes that contain a biologically active terminal GKP- D -V anti-inflammatory peptide by a rapid "dip-and-dry" forming method. The growth of neural Schwann and fibroblast cells on a layer of resorcinarene-GKP- D -V demonstrate inhibition of inflammatory signaling. [source] Quantitative Chemical Mapping of Relevant Trace Elements at Biomaterials/Biological Media Interfaces by Ion Beam MethodsADVANCED ENGINEERING MATERIALS, Issue 7 2010Edouard Jallot The definition of biomaterial as proposed by the European Society for Biomaterials in 1986 puts forward the overall importance of the notion of contact between the biomaterial and biological medium (cell, tissue, fluid,,). The underlying concept of biocompatibility makes the interface between biomaterial and biological medium a privileged zone of interest. In this paper, we would like to give an exhaustive view of how ion beams techniques can contribute to a better understanding of such interface taking several examples dealing with bone tissue substitution. After a short presentation of ion beams techniques the paper will focus on PIXE/RBS spectroscopies and will give the basics of these coupled technique. Three examples will then be presented to illustrate the interest of these techniques to study biomaterials/biological interactions. The first example deals with metallic alloys based joint prostheses. The ionic release from the prosthesis and the wear behavior of total knee prostheses will be presented. In the last two examples, bioactive materials will be studied. The common characteristic of bioactive ceramics is the kinetic modification of their surface upon interaction which is ideally monitored by PIXE chemical mapping. The second example will review the benefit of using PIXE/RBS technique to study the effect of doping of bioactive glasses on the very first steps involved in the bioactivity mechanisms like dissolution, ionic release, and biomineralization onto the surface of the glasses. Finally, protein delivery systems based upon mesoporous hydroxyapatites will be studied. Chemical mapping allowing the quantitative determination of protein distribution inside the HAp grains will be presented for the first time. [source] Bioactive and mechanically strong Bioglass®-poly(D,L -lactic acid) composite coatings on surgical suturesJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2006Q. Z. Chen Abstract New coating processes have been investigated for degradable (Vicryl®) and nondegradable (Mersilk®) sutures with the aim to develop Bioglass® coated polymer fibers for wound healing and tissue engineering scaffold applications. First, the aqueous phase of a Bioglass® particle slurry was replaced with a poly(D,L -lactic acid) (PDLLA) polymer dissolved in solvent dimethyle carbonate (DMC) to act as third phase. SEM observations indicated that this alteration significantly improved the homogeneity of the coatings. Second, a new coating strategy involving two steps was developed: the sutures were first coated with a Bioglass®,PDLLA composite film followed by a second PDLLA coating. This two-step process of coating has addressed the problem of poor adherence of Bioglass® particles on suture surfaces. The coated sutures were knotted to determine qualitatively the mechanical integrity of the coatings. The results indicated that adhesion strength of coatings obtained by the two-step method was remarkably enhanced. A comparative assessment of the bioactivity of one-step and two-step produced coatings was carried out in vitro using acellular simulated body fluid (SBF) for up to 28 days. Coatings produced by the two-step process were found to have similar bioactivity as the one-step produced coatings. The novel Bioglass®/PDLLA/Vicryl® and Bioglass®/PDLLA/Mersilk® composite sutures are promising bioactive materials for wound healing and tissue engineering applications. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006 [source] Development of New Microencapsulation Techniques Useful for the Preparation of PLGA MicrospheresMACROMOLECULAR RAPID COMMUNICATIONS, Issue 21 2006Hongkee Sah Abstract Summary: Intensive efforts were made to develop an efficient, novel microencapsulation system useful to encapsulate a model drug, risperidone, to PLGA microspheres. Methyl dichloroacetate was used as a dispersed solvent for the first time, since it possessed excellent solvency power on PLGA and readily underwent ammonolysis. A dispersed phase composed of methyl dichloroacetate, risperidone, and PLGA was emulsified in an aqueous phase to form an O/W emulsion. Adding ammonia solution into the emulsion rapidly converted methyl dichloroacetate into water-soluble dichloroacetamide and methanol. As a result, emulsion droplets were immediately transformed into hardened microspheres. The new microencapsulation system allowed us to make PLGA microspheres with a drug payload of >40 wt.-% and attain almost complete encapsulation efficiencies. In summary, preparing an O/W emulsion and subjecting the emulsion to ammonolysis led to development of an efficient, novel microencapsulation system. It was anticipated that the new system could make it possible to load other bioactive materials into microspheres made of various types of hydrophobic polymers. SEM micrographs of the external and internal morphology of PLGA/risperidone microspheres. [source] | ||||||||||